Business Daily.
.
The Times Real Estate
A+ R A-

The Lancet: Trial confirms Ebola vaccine candidate safe and equally immunogenic in Africa

E-mail Print PDF
Two experimental DNA vaccines to prevent Ebola virus and the closely related Marburg virus [1] are safe, and generated a similar immune response in healthy Ugandan adults as reported in healthy US adults earlier this year. The findings, from the first trial of filovirus vaccines in Africa, are published in The Lancet.

Read more http://www.alphagalileo.org/ViewItem.aspx?ItemId=148447&CultureCode=en

Business Daily Media